Acquisition

RNS Number : 9043J

Compagnie de Saint-Gobain

21 August 2023

 

 

 

 

 

 

 

 

SAINT-GOBAIN expects to COMPLETE ITS ACQUISITIONOF bUILDING pRODUCTS OF CANADA ON SEPTEMBER 1st, 2023

 

 

Saint-Gobain has now obtained approval from the Competition Bureau of Canada for its acquisition announced on June 12, 2023 of Building Products of Canada, a privately owned manufacturer of residential roofing shingles and wood fiber insulation panels in Canada. The acquisition is expected to close on September 1st, 2023.

 

With this acquisition, Saint-Gobain takes a logical step to reinforce its leadership in light and sustainable construction in Canada by completing its offer on Exterior Solutions in the country with Roofing, following the addition of Siding thanks to the Kaycan acquisition in 2022. The acquisition therefore complements the existing CertainTeed Canada operations, already leader in Interior Solutions (gypsum, insulation, ceilings).

 

 

 

ABOUT SAINT-GOBAIN

Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufacturesand distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonizationof construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group's commitment is guided by its purpose,"MAKING THE WORLD A BETTER HOME".

 

€51.2 billion in sales in 2022

168,000 employees, locations in 75 countries

Committed to achieving Carbon Neutrality by 2050

 

For more information about Saint-Gobain,visit www.saint-gobain.com and follow us on Twitter @saintgobain

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.